FOS and skin basal cell carcinoma: Indeed, we see that in naive human BCC explants, tumors containing nuclear MRTF respond significantly to AP-1 inhibition with a decrease in Gli1 expression, while tumors with only cytoplasmic MRTF are less responsive.